Cong Vu Thanh

Cong Vu Thanh

Auto-generated profile, based on publicly available information

Cong Vu Thanh

NanoSoils Bio Pty Ltd, Sydney, Australia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2022 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
VCVu Thanh Cong
Vu Thanh Cong
JHJacinta L. Houng
Jacinta L. Houng
MKMaria Kavallaris
Maria Kavallaris
Xin ChenXin Chen
Xin Chen
RTRichard Tilley
Richard Tilley
J. GoodingJ. Gooding
J. Gooding
Targeted drug delivery in cancer typically focuses on maximising the endocytosis of drugs into the diseased cells. However, there has been less focus on exploiting the differences in the endocytosis pathways of cancer cells versus non-cancer cells. An understanding of the endocytosis pathways in both cancer and non-cancer cells allows for the design of nanoparticles to deliver drugs to cancer cells whilst restricting healthy cells from taking up anticancer drugs, thus efficiently killing the cancer cells. Herein we compare the differences in the endocytosis pathways of cancer and healthy cells. Second, we highlight the importance of the physicochemical properties of nanoparticles (size, shape, stiffness, and surface chemistry) on cellular uptake and how they can be adjusted to selectively target the dominated endocytosis pathway of cancer cells over healthy cells and to deliver anticancer drug to the target cells. The review generates new thought in the design of cancer-selective nanoparticles based on the endocytosis pathways.

7 March 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
CTCong Vu Thanh
Cong Vu Thanh
J. GoodingJ. Gooding
J. Gooding
MKMelanie Kah
Melanie Kah
Sharing concepts and knowledge between medical and agricultural fields can promote the development of improved nano-enabled technologies. A central idea behind drug delivery systems is that the active substances are encapsulated in nanoparticles (nano-medicines) to protect the drugs from premature degradation and allow them to be transported to the target site within the body. After three decades of development, nano-medicines are now used in many practical applications, including clinical oncology, infectious disease, cosmetics, and vaccines. Nano-agrochemicals are increasingly considered to tackle challenges associated with food production, sustainability and food security. Despite obvious differences between nano-medicines and nano-agrochemicals in terms of uptake mechanisms, target and environmental and economic constraints, the principles behind nanoparticle design share many similarities. This article hopes to share experiences and lessons learnt from nano-medicines that will help design more effective and safer nano-agrochemicals.